Osteoporosis in the age of COVID-19

Virtually Perfect? Telemedicine for Covid-19

(2020) Judd E. Hollander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Women’s Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review

(2019) Patricia Barrionuevo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fracture risk following intermission of osteoporosis therapy

(2019) E.M. Dennison et al.   OSTEOPOROSIS INTERNATIONAL

ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY

(2018) Chiara Crotti et al.   Endocrine Practice

Risk of subsequent fracture after prior fracture among older women

(2018) A. Balasubramanian et al.   OSTEOPOROSIS INTERNATIONAL

Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

(2017) Athanasios D Anastasilakis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial

(2017) Steven L Watson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis in Crisis: It's Time to Focus on Fracture

(2017) Neil Binkley et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate

(2017) A.W. Popp et al.   OSTEOPOROSIS INTERNATIONAL

External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study

(2014) Luai A. Ahmed et al.   PLoS One